Where is LEXEO headquartered?

LEXEO is located in New York, NY.

Who invested in LEXEO?

LEXEO has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for LEXEO?

LEXEO closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

lexeotx.com

LEXEO

LEXEO Therapeutics is a New York-based biotechnology company that develops and commercializes AAV-mediated treatments for genetic diseases.

Business Model:

Revenue: $4.4M

Employees: 11-50

Geographic Data

Address: 430 East 29th Street

City: New York

State: NY

Zip: 10013

Country: US

Financial Info

Stage:

series b

Raised Last:

$100M

Raised Total:

$185M

Social

Crunchbase

Metrics

4,837,072Website Global Rank

1,773Website Monthly Traffic

Twitter Followers

Description

LEXEO Therapeutics is a New York-based biotechnology company that develops and commercializes AAV-mediated treatments for genetic diseases.

Contact Phone:
+12125479879

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2021	Series B		$0	Alexandria Venture Investments CAM Capital D1 Capital Partners Eventide Gray’s Creek Capital Partners Intus Capital Janus Henderson Investors Laurion Capital Management Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Verition Fund Management Woodline Partners Alexandria Venture Investments CAM Capital D1 Capital Partners Eventide Gray’s Creek Capital Partners Intus Capital Janus Henderson Investors Laurion Capital Management Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Verition Fund Management Woodline Partners
1/2021	Series A		$0	Alexandria Venture Investments Alzheimer&s;s Drug Discovery Foundation Invus Janus Henderson Investors Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Woodline Partners Alexandria Venture Investments Alzheimer&s;s Drug Discovery Foundation Invus Janus Henderson Investors Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Woodline Partners
9/2021	Series B	14	$100M	Eventide Asset Management CAM Capital Verition Fund Management Laurion Capital Management Gray’s Creek Capital Partners Longitude Capital PBM Capital Janus Henderson Investors Woodline Partners LP Invus Capital Alexandria Venture Investments CAM Capital D1 Capital Partners Eventide Gray’s Creek Capital Partners Intus Capital Janus Henderson Investors Laurion Capital Management Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Verition Fund Management Woodline Partners
1/2021	Series A	9	$85M	Longitude Capital PBM Capital Janus Henderson Investors Invus Woodline Partners LP Alzheimer’s Drug Discovery Foundation Alexandria Venture Investments Alexandria Venture Investments Alzheimer&s;s Drug Discovery Foundation Invus Janus Henderson Investors Longitude Capital Lundbeckfonden Ventures Omega Funds PBM Capital Group Woodline Partners

Acquisitions

Announced Date	Name	Price
7/2021	Stelios Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details